About the role
Who we are
Aizon is a software-as-a-service provider that transforms manufacturing operations in life science industries using advanced analytics and artificial intelligence.
Following our recent Series C round of growth funding, we are looking for ambitious new team members motivated to directly impact our future growth and success as we launch what we consider “Aizon 3.0”.
Aizon is helping pharma manufacturers and CDMOs make better decisions in GMP operations.
What makes us different from other manufacturing platforms?
- We help operations leaders and engineers avoid endless cycles of chasing data in disparate and heavy-handed systems and rapidly understand how to run their manufacturing processes better.
- We’re solving multiple problems in GMP operations that cost manufacturers millions yearly while accelerating their digital maturity journey. One of our unique capabilities is the ability to operationalize the use of predictive AI models in real-time without a big data science staff.
- We’re backed by both industry and software investor firms like NewVale Capital, Atlantic Bridge, Danaher, Honeywell, CrossLink, and UnCork, with solid industry and technology expertise.
Our mission is to improve global health by optimizing how medicines are manufactured so that pharma and biotech companies can provide patients worldwide with the right medicine at the right time and price.
Join us if you are motivated to directly impact our company's success and growth path forward and, more importantly, by positively contributing to the life science industry and deserving patients worldwide.
The Position:
Report to: QC Lead
The Advanced QA Automation Engineer is the automation cornerstone of Aizon’s Quality Control department. This role designs, builds, and continuously evolves automated testing frameworks that cover both Aizon Execute (iBR) and Aizon Platform (Unify &; Predict) — two SaaS solutions are deployed in highly regulated GxP pharmaceutical environments.
By transforming manual test scripts into reliable, self-documenting automated suites that produce human-readable, audit-ready evidence, this engineer enables faster release cycles, stronger quality gates, and greater confidence for our pharma and biotech customers worldwide.